Optic atrophy after sildenafil use

Optometry

Volumn 78, Issue 3, 2007, Pages 122-128

  Sowka, Joseph W ^a   Neiberg, Maryke N ^a   Vollmer, Lori A ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Erectile enhancing medications; Nonarteritic anterior ischemic optic neuropathy; Optic atrophy; Optic neuropathy; Phosphodiesterase inhibitor; Sildenafil

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SILDENAFIL; SULFONE;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; FOLLOW UP; HUMAN; IMPOTENCE; MALE; OPTIC NERVE ATROPHY; PATHOLOGY; PATHOPHYSIOLOGY; PERIMETRY; VISUAL ACUITY; VISUAL FIELD;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; AGED; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; MALE; OPTIC ATROPHY; PERIMETRY; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SULFONES; VISUAL ACUITY; VISUAL FIELDS;

EID: 33847096734     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2007.01.005     Document Type: Article

References (29)

1. Marmor M.F., and Kessler R. Sildenafil (Viagra) and ophthalmology. Surv Ophthalmol 44 2 (1999) 153-162
2. Jagle H., Jagle C., Serey L., et al. Visual short-term effects of Viagra: double blind study in healthy young subjects. Am J Ophthalmol 137 5 (2004) 842-849
3. Cunningham A.V., and Smith K.H. Anterior ischemic optic neuropathy associated with Viagra. J Neuro-Ophthalmol 21 1 (2001) 22-25
4. Morgan J.C., Alhatou M., Oberlies J., et al. Transient ischemic attack and stroke associated with sildenafil (Viagra). Neurology 57 9 (2001) 1730-1731
5. Donahue S.P., and Taylor R.J. Pupil sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol 126 3 (1998) 476-477
6. Egan R., and Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 118 2 (2000) 291-292
7. Porst H. Erectile dysfunction. New drugs with special consideration of the PDE 5 inhibitors. Der Urologe 43 7 (2004) 820-828
8. Lincoln T.M. Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon?. Mol Pharmocol 66 1 (2004) 11-13
9. Allibhai Z.A., Gale J.S., and Sheidow T.S. Central serous chorioretinopathy in a patient taking sildenafil citrate. Ophthalmic Surg Lasers Imaging 35 2 (2004) 165-167
10. Gruhn N., and Fledelius H.C. Unilateral optic neuropathy associated with sildenafil intake. Acta Ophthalomologica Scandinavica 83 1 (2005) 131-132
11. Bollinger K., and Lee M.S. Recurrent visual field defect and ischemic optic neuropathy associated with Tadalafil rechallenge. Arch Ophthalmol 123 3 (2005) 400-401
12. FDA Food and Drug administration. Memorandum 8, May 1998.
13. Laties A., and Zrenner E. Viagra (sildenafil citrate) and ophthalmology. Progress in Retinal Eye & Research 21 5 (2002) 485-506
14. Balacco G.C., Regine F., Vingolo E.M., et al. Acute electroretinographic changes during sildenafil (Viagra) treatment for treatment of erectile dysfunction. Doc Ophthalmologica 107 2 (2003) 111-114
15. Keating G.M., and Scott L.J. Vardenafil: a review of its use in erectile dysfunction. Drugs 63 23 (2003) 2673-2703
16. Gabrieli C.B., Regine F., Vingolo E.M., et al. Subjective visual halos after sildenafil (Viagra) administration: electroretinographic evaluation. Ophthalmology 108 5 (2001) 877-881
17. Luu J.K., Chappelow A.V., McCully T.J., et al. Acute effects of Sildenafil on the electroretinogram and multifocal electroretinogram. Am J Ophthalmol 132 3 (2001) 388-394
18. Paris G., Sponsel W.E., Sandoval S.S., et al. Sildenafil increases ocular perfusion. Int Ophthalmol 23 4-6 (2001) 355-358
19. Dundar S.O., Dundar M., Kocak I., et al. Effect of sildenafil on ocular heamodynamics. Eye 15 Pt 4 (2001) 507-510
20. Kurtulan E., Gulcu A., Secil M., et al. Effects of sildenafil on ocular perfusion demonstrated by color Doppler ultrasonography. Intl J Impot Res 16 3 (2004) 244-248
21. Grunwald J.E., Metelitsina T., and Grunwald L. Effect of sildenafil citrate (Viagra) on retinal blood vessel diameter. Am J Ophthalmol 133 6 (2002) 809-812
22. Bertolucci A., Latkany R.A., Gentile R.C., et al. Hemi-retinal artery occlusion associated with sexual activity and sildenafil citrate (Viagra). Acta Ophthalmol Scand 81 2 (2003) 198-200
23. Pomeranz H.D., Smith K.H., Hart W.M., et al. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology 109 3 (2002) 584-587
24. Pomeranz H.D., and Bhavasar A.R. Nonarteritic ischemic optic neuropathy developing soon after use of Sildenafil (Viagra): a report of seven new cases. J Neuro-Ophthalmol 25 1 (2005) 9-13
25. FDA Alert (07/2005) for Healthcare professionals. Sildenafil citrate(Viagra) FDA.
26. Escaravage Jr. G.K., Wright J.D., and Givre S.J. Tadalafil associated with anterior ischemic optic neuropathy. Arch Ophthalmol 123 3 (2005) 399-400
27. Egan R.A., and Frauenfelder F.W. Viagra and anterior ischemic neuropathy. Arch Ophthalmol 123 5 (2005) 709-710
28. McGwin Jr. G., Vaphiades M.S., Hall T.A., et al. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol 90 2 (2006) 154-157
29. Hayreh S.S., and Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol 123 11 (2005) 1554-1562